Directed differentiation and maturation of pluripotent cells into hepatocyte like cells by modulation of wnt-signalling pathway
AssigneeCellartis AB
InventorsGabriella Brolén, Josefina Edsbagge
Life of this patent
Estimating the term…
Loading patent…
AssigneeCellartis AB
InventorsGabriella Brolén, Josefina Edsbagge
Estimating the term…
Provided are improved methods using Glycogen synthase kinase 3 (GSK3) inhibitors by which endodermal cells, notably endodermal cells derived from human pluripotent stem cells (hPS), such as but not limited to hiPS-cells and hES-cells may be differentiated into hepatocyte like cells. The specific modulation of wingless integration gene (WNT)-signalling pathway and use of GSK3 inhibitors achieve direct differentiation and maturation of hepatocytes derived from human pluripotent stem (hPS) cells. GSK-3 inhibitors, when added to the growth medium at certain developmental stages, leads to more mature and functional features for the hepatocyte like cells as well as more pure and homogenous populations of hepatocyte like cells. Provided are also hepatocyte like cells obtained by these methods as well as compositions comprising them.
-38. (canceled)
A method for directing the differentiation of endodermal cells into hepatocyte-like cells using a GSK-3 inhibitor, wherein said method comprises:
A method for the preparation of hepatocyte-like cells comprising:
An isolated in vitro-derived hepatocyte-like cell in a medium comprising a GSK-3 inhibitor.
A composition comprising in vitro derived hepatocyte-like cells and a GSK-3 inhibitor.
A composition comprising isolated in vitro-derived human cells, wherein at least 70% of the cells are hepatocyte-like cells.
Dependencies are inferred from the claim text.